{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:10:01Z","timestamp":1748967001999,"version":"3.41.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00059-025-05299-w","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:55:01Z","timestamp":1741100101000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision medicine in the management of valvular heart disease","Pr\u00e4zisionsmedizin beim Management von Herzklappenerkrankungen"],"prefix":"10.1007","volume":"50","author":[{"given":"Felix S.","family":"Nettersheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"12","key":"5299_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","volume":"18","author":"S Coffey","year":"2021","unstructured":"Coffey\u00a0S, Roberts-Thomson\u00a0R, Brown\u00a0A et\u00a0al (2021) Global epidemiology of valvular heart disease. Nat Rev Cardiol 18(12):853\u2013864. https:\/\/doi.org\/10.1038\/s41569-021-00570-z","journal-title":"Nat Rev Cardiol"},{"key":"5299_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo\u00a0VT, Gardin\u00a0JM, Skelton\u00a0TN et\u00a0al (2006) Burden of valvular heart diseases: a\u00a0population-based study. Lancet 368:1005\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(06)69208-8","journal-title":"Lancet"},{"key":"5299_CR3","volume-title":"Deutscher Herzbericht \u2013 Update 2024","author":"T Voigtl\u00e4nder","year":"2024","unstructured":"Voigtl\u00e4nder\u00a0T, Schunkert\u00a0H, Vestweber\u00a0M (2024) Deutscher Herzbericht \u2013 Update 2024. Georg-Thieme Verlag KG, Stuttgart"},{"key":"5299_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/EURHEARTJ\/EHAB395","author":"A Vahanian","year":"2021","unstructured":"Vahanian\u00a0A, Beyersdorf\u00a0F, Praz\u00a0F et\u00a0al (2021) 2021 ESC\/EACTS guidelines for the management of valvular heart diseasedeveloped by the task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB395","journal-title":"Eur Heart J"},{"key":"5299_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/NRCARDIO.2010.202","volume":"8","author":"B Iung","year":"2011","unstructured":"Iung\u00a0B, Vahanian\u00a0A (2011) Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 8:162\u2013172. https:\/\/doi.org\/10.1038\/NRCARDIO.2010.202","journal-title":"Nat Rev Cardiol"},{"key":"5299_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/J.JACC.2013.05.015","volume":"62","author":"RLJ Osnabrugge","year":"2013","unstructured":"Osnabrugge\u00a0RLJ, Mylotte\u00a0D, Head\u00a0SJ et\u00a0al (2013) Aortic Stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a\u00a0meta-analysis and modeling study. J\u00a0Am Coll Cardiol 62:1002\u20131012. https:\/\/doi.org\/10.1016\/J.JACC.2013.05.015","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR7","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/J.JACC.2023.09.796\/SUPPL_FILE\/MMC1.DOCX","volume":"82","author":"P G\u00e9n\u00e9reux","year":"2023","unstructured":"G\u00e9n\u00e9reux\u00a0P, Sharma\u00a0RP, Cubeddu\u00a0RJ et\u00a0al (2023) The mortality burden of untreated aortic Stenosis. J\u00a0Am Coll Cardiol 82:2101\u20132109. https:\/\/doi.org\/10.1016\/J.JACC.2023.09.796\/SUPPL_FILE\/MMC1.DOCX","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR8","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia\u00a0SR, Leon\u00a0MB, Makkar\u00a0RR et\u00a0al (2015) 5\u2011year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER\u00a01): a\u00a0randomised controlled trial. Lancet 385:2485\u20132491. https:\/\/doi.org\/10.1016\/S0140-6736(15)60290-2","journal-title":"Lancet"},{"key":"5299_CR9","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/J.JACC.2023.09.813","volume":"82","author":"JK Forrest","year":"2023","unstructured":"Forrest\u00a0JK, Deeb\u00a0GM, Yakubov\u00a0SJ et\u00a0al (2023) 4\u2011year outcomes of patients with aortic stenosis in the evolut low risk trial. J\u00a0Am Coll Cardiol 82:2163\u20132165. https:\/\/doi.org\/10.1016\/J.JACC.2023.09.813","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR10","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","volume":"385","author":"MJ Mack","year":"2015","unstructured":"Mack\u00a0MJ, Leon\u00a0MB, Smith\u00a0CR et\u00a0al (2015) 5\u2011year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER\u00a01): A\u00a0randomised controlled trial. Lancet 385:2477\u20132484. https:\/\/doi.org\/10.1016\/S0140-6736(15)60308-7","journal-title":"Lancet"},{"key":"5299_CR11","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMOA2307447\/SUPPL_FILE\/NEJMOA2307447_DATA-SHARING.PDF","volume":"389","author":"MJ Mack","year":"2023","unstructured":"Mack\u00a0MJ, Leon\u00a0MB, Thourani\u00a0VH et\u00a0al (2023) Transcatheter aortic-valve replacement in low-risk patients at five years. N\u00a0Engl J Med 389:1949\u20131960. https:\/\/doi.org\/10.1056\/NEJMOA2307447\/SUPPL_FILE\/NEJMOA2307447_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMOA1910555\/SUPPL_FILE\/NEJMOA1910555_DATA-SHARING.PDF","volume":"382","author":"RR Makkar","year":"2020","unstructured":"Makkar\u00a0RR, Thourani\u00a0VH, Mack\u00a0MJ et\u00a0al (2020) Five-year outcomes of Transcatheter or surgical aortic-valve replacement. N\u00a0Engl J Med 382:799\u2013809. https:\/\/doi.org\/10.1056\/NEJMOA1910555\/SUPPL_FILE\/NEJMOA1910555_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/JAMACARDIO.2022.2695","volume":"7","author":"NM Van Mieghem","year":"2022","unstructured":"Van Mieghem\u00a0NM, Deeb\u00a0GM, S\u00f8ndergaard\u00a0L et\u00a0al (2022) Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5\u2011year outcomes of the SURTAVI randomized clinical trial. JAMA Cardiol 7:1000\u20131008. https:\/\/doi.org\/10.1001\/JAMACARDIO.2022.2695","journal-title":"JAMA Cardiol"},{"key":"5299_CR14","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/J.JACC.2018.08.2146","volume":"72","author":"TG Gleason","year":"2018","unstructured":"Gleason\u00a0TG, Reardon\u00a0MJ, Popma\u00a0JJ et\u00a0al (2018) 5\u2011year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J\u00a0Am Coll Cardiol 72:2687\u20132696. https:\/\/doi.org\/10.1016\/J.JACC.2018.08.2146","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/EURHEARTJ\/EHAE043","volume":"45","author":"HG H\u00f8rsted Thyregod","year":"2024","unstructured":"H\u00f8rsted Thyregod\u00a0HG, J\u00f8rgensen\u00a0TH, Ihlemann\u00a0N et\u00a0al (2024) Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart\u00a0J 45:1116\u20131124. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAE043","journal-title":"Eur Heart J"},{"key":"5299_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMOA2400685\/SUPPL_FILE\/NEJMOA2400685_DATA-SHARING.PDF","volume":"390","author":"S Blankenberg","year":"2024","unstructured":"Blankenberg\u00a0S, Seiffert\u00a0M, Vonthein\u00a0R et\u00a0al (2024) Transcatheter or surgical treatment of aortic-valve stenosis. N\u00a0Engl J Med 390:1572\u20131583. https:\/\/doi.org\/10.1056\/NEJMOA2400685\/SUPPL_FILE\/NEJMOA2400685_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR17","doi-asserted-by":"publisher","first-page":"E72","DOI":"10.1161\/CIR.0000000000000923","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto\u00a0CM, Nishimura\u00a0RA, Bonow\u00a0RO et\u00a0al (2021) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a\u00a0report of the american college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 143:E72\u2013E227","journal-title":"Circulation"},{"key":"5299_CR18","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.4244\/EIJ-D-23-01050","volume":"20","author":"J Ternacle","year":"2024","unstructured":"Ternacle\u00a0J, Hecht\u00a0S, Eltchaninoff\u00a0H et\u00a0al (2024) Durability of transcatheter aortic valve implantation. EuroIntervention 20:e845\u2013e864. https:\/\/doi.org\/10.4244\/EIJ-D-23-01050","journal-title":"EuroIntervention"},{"key":"5299_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0140-6736(23)01636-7","volume":"402","author":"RR Makkar","year":"2023","unstructured":"Makkar\u00a0RR, Kapadia\u00a0S, Chakravarty\u00a0T et\u00a0al (2023) Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a\u00a0registry study. Lancet 402:1529\u20131540. https:\/\/doi.org\/10.1016\/S0140-6736(23)01636-7","journal-title":"Lancet"},{"key":"5299_CR20","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/J.JACC.2020.02.051","volume":"75","author":"U Landes","year":"2020","unstructured":"Landes\u00a0U, Webb\u00a0JG, De Backer\u00a0O et\u00a0al (2020) Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J\u00a0Am Coll Cardiol 75:1882\u20131893. https:\/\/doi.org\/10.1016\/J.JACC.2020.02.051","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR21","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1093\/EURHEARTJ\/EHAE331","volume":"45","author":"TH J\u00f8rgensen","year":"2024","unstructured":"J\u00f8rgensen\u00a0TH, Thyregod\u00a0HGH, Savontaus\u00a0M et\u00a0al (2024) Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2\u00a0trial. Eur Heart\u00a0J 45:3804\u20133814. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAE331","journal-title":"Eur Heart J"},{"key":"5299_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1912846","volume":"382","author":"D-H Kang","year":"2020","unstructured":"Kang\u00a0D\u2011H, Park\u00a0S\u2011J, Lee\u00a0S\u2011A et\u00a0al (2020) Early surgery or conservative care for asymptomatic aortic stenosis. N\u00a0Engl J Med 382:111\u2013119. https:\/\/doi.org\/10.1056\/NEJMoa1912846","journal-title":"N Engl J Med"},{"key":"5299_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1161\/CIRCULATIONAHA.121.057639","volume":"145","author":"M Banovic","year":"2022","unstructured":"Banovic\u00a0M, Putnik\u00a0S, Penicka\u00a0M et\u00a0al (2022) Aortic valve replacement versus conservative treatment in asymptomatic severe aortic Stenosis: the AVATAR trial. Circulation 145:648\u2013658. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057639","journal-title":"Circulation"},{"key":"5299_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2024.22730","author":"K Loganath","year":"2024","unstructured":"Loganath\u00a0K, Craig\u00a0NJ, Everett\u00a0RJ et\u00a0al (2024) Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the EVOLVED randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/JAMA.2024.22730","journal-title":"JAMA"},{"key":"5299_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2405880\/SUPPL_FILE\/NEJMOA2405880_DATA-SHARING.PDF","author":"P G\u00e9n\u00e9reux","year":"2024","unstructured":"G\u00e9n\u00e9reux\u00a0P, Schwartz\u00a0A, Oldemeyer\u00a0JB et\u00a0al (2024) Transcatheter aortic-valve replacement for asymptomatic severe aortic Stenosis. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2405880\/SUPPL_FILE\/NEJMOA2405880_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/J.JACC.2023.01.032","volume":"81","author":"KR Khan","year":"2023","unstructured":"Khan\u00a0KR, Khan\u00a0OA, Chen\u00a0C et\u00a0al (2023) Impact of moderate aortic stenosis in patients with heart failure with reduced ejection fraction. J\u00a0Am Coll Cardiol 81:1235\u20131244. https:\/\/doi.org\/10.1016\/J.JACC.2023.01.032","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2024.10.070","author":"NM Van Mieghem","year":"2024","unstructured":"Van Mieghem\u00a0NM, Elmariah\u00a0S, Spitzer\u00a0E et\u00a0al (2024) Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis: TAVR UNLOAD. J\u00a0Am Coll Cardiol. https:\/\/doi.org\/10.1016\/J.JACC.2024.10.070","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/24748706.2021.1988779","volume":"5","author":"VH Thourani","year":"2021","unstructured":"Thourani\u00a0VH, Brennan\u00a0JM, Edelman\u00a0JJ et\u00a0al (2021) Treatment patterns, disparities, and management strategies impact clinical outcomes in patients with symptomatic severe aortic regurgitation. Struct Hear 5:608\u2013618. https:\/\/doi.org\/10.1080\/24748706.2021.1988779","journal-title":"Struct Hear"},{"key":"5299_CR29","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","volume":"403","author":"TP Vahl","year":"2024","unstructured":"Vahl\u00a0TP, Thourani\u00a0VH, Makkar\u00a0RR et\u00a0al (2024) Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a\u00a0prospective, multicentre, single-arm study. Lancet 403:1451\u20131459. https:\/\/doi.org\/10.1016\/S0140-6736(23)02806-4","journal-title":"Lancet"},{"key":"5299_CR30","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/J.JCIN.2023.07.038\/SUPPL_FILE\/MMC1.PPTX","volume":"16","author":"M Adam","year":"2023","unstructured":"Adam\u00a0M, Tamm\u00a0A, Wienemann\u00a0H et\u00a0al (2023) Transcatheter aortic valve replacement for isolated aortic regurgitation using a\u00a0new self-expanding TAVR system. JACC Cardiovasc Interv 16:1965\u20131973. https:\/\/doi.org\/10.1016\/J.JCIN.2023.07.038\/SUPPL_FILE\/MMC1.PPTX","journal-title":"JACC Cardiovasc Interv"},{"key":"5299_CR31","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/J.JCIN.2023.05.018","volume":"16","author":"S Garcia","year":"2023","unstructured":"Garcia\u00a0S, Ye\u00a0J, Webb\u00a0J et\u00a0al (2023) Transcatheter treatment of native aortic valve regurgitation: the north American experience with a\u00a0novel device. Cardiovasc Interv 16:1953\u20131960. https:\/\/doi.org\/10.1016\/J.JCIN.2023.05.018","journal-title":"Cardiovasc Interv"},{"key":"5299_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","volume":"391","author":"V Dziadzko","year":"2018","unstructured":"Dziadzko\u00a0V, Clavel\u00a0M\u2011A, Dziadzko\u00a0M et\u00a0al (2018) Outcome and undertreatment of mitral regurgitation: a\u00a0community cohort study. Lancet 391:960\u2013969. https:\/\/doi.org\/10.1016\/S0140-6736(18)30473-2","journal-title":"Lancet"},{"key":"5299_CR33","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/eurheartj\/ehx465","volume":"39","author":"F Grigioni","year":"2018","unstructured":"Grigioni\u00a0F, Clavel\u00a0M\u2011A, Vanoverschelde\u00a0J\u2011L et\u00a0al (2018) The MIDA mortality risk score: development and external validation of a\u00a0prognostic model for early and late death in degenerative mitral regurgitation. Eur Heart\u00a0J 39:1281\u20131291. https:\/\/doi.org\/10.1093\/eurheartj\/ehx465","journal-title":"Eur Heart J"},{"key":"5299_CR34","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"J-F Obadia","year":"2018","unstructured":"Obadia\u00a0J\u2011F, Messika-Zeitoun\u00a0D, Leurent\u00a0G et\u00a0al (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N\u00a0Engl J Med 379:2297\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1805374","journal-title":"N Engl J Med"},{"key":"5299_CR35","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone\u00a0GW, Lindenfeld\u00a0J, Abraham\u00a0WT et\u00a0al (2018) Transcatheter mitral-valve repair in patients with heart failure. N\u00a0Engl J Med 379:2307\u20132318. https:\/\/doi.org\/10.1056\/NEJMoa1806640","journal-title":"N Engl J Med"},{"key":"5299_CR36","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1016\/J.JCIN.2023.09.029","volume":"16","author":"RS von Bardeleben","year":"2023","unstructured":"von Bardeleben\u00a0RS, Mahoney\u00a0P, Morse\u00a0MA et\u00a0al (2023) 1\u2011year outcomes with fourth-generation mitral valve transcatheter edge-to-edge repair from the EXPAND G4 study. JACC Cardiovasc Interv 16:2600\u20132610. https:\/\/doi.org\/10.1016\/J.JCIN.2023.09.029","journal-title":"JACC Cardiovasc Interv"},{"key":"5299_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCHF.2024.08.001","author":"AW Asgar","year":"2024","unstructured":"Asgar\u00a0AW, Tang\u00a0GHL, Rogers\u00a0JH et\u00a0al (2024) Evaluating mitral TEER in the management of moderate secondary mitral regurgitation among heart failure patients. JACC Heart Fail. https:\/\/doi.org\/10.1016\/J.JCHF.2024.08.001","journal-title":"JACC Heart Fail"},{"key":"5299_CR38","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/J.JCIN.2022.07.004","volume":"15","author":"SH Yoon","year":"2022","unstructured":"Yoon\u00a0SH, Makar\u00a0M, Kar\u00a0S et\u00a0al (2022) Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling. JACC Cardiovasc Interv 15:1711\u20131722. https:\/\/doi.org\/10.1016\/J.JCIN.2022.07.004","journal-title":"JACC Cardiovasc Interv"},{"key":"5299_CR39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2314328\/SUPPL_FILE\/NEJMOA2314328_DATA-SHARING.PDF","author":"SD Anker","year":"2024","unstructured":"Anker\u00a0SD, Friede\u00a0T, von Bardeleben\u00a0R\u2011S et\u00a0al (2024) Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2314328\/SUPPL_FILE\/NEJMOA2314328_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2408739\/SUPPL_FILE\/NEJMOA2408739_DATA-SHARING.PDF","author":"S Baldus","year":"2024","unstructured":"Baldus\u00a0S, Doenst\u00a0T, Pfister\u00a0R et\u00a0al (2024) Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2408739\/SUPPL_FILE\/NEJMOA2408739_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR41","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/J.JCIN.2023.10.002","volume":"16","author":"F Zahr","year":"2023","unstructured":"Zahr\u00a0F, Smith\u00a0RL, Gillam\u00a0LD et\u00a0al (2023) 1\u2011year outcomes from the CLASP IID randomized trial for degenerative mitral regurgitation. Cardiovasc Interv 16:2803\u20132816. https:\/\/doi.org\/10.1016\/J.JCIN.2023.10.002","journal-title":"Cardiovasc Interv"},{"key":"5299_CR42","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/J.JACC.2021.08.060","volume":"78","author":"DWM Muller","year":"2021","unstructured":"Muller\u00a0DWM, Sorajja\u00a0P, Duncan\u00a0A et\u00a0al (2021) 2\u2011year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation. J\u00a0Am Coll Cardiol 78:1847\u20131859. https:\/\/doi.org\/10.1016\/J.JACC.2021.08.060","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR43","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4244\/EIJ-D-23-00596","volume":"19","author":"J Curio","year":"2023","unstructured":"Curio\u00a0J, Kuhn\u00a0EW, K\u00f6rber\u00a0MI et\u00a0al (2023) Electrosurgical laceration and stabilisation of three clip devices (ELASTA-clip) to enable transcatheter mitral valve implantation. EuroIntervention 19:744\u2013745. https:\/\/doi.org\/10.4244\/EIJ-D-23-00596","journal-title":"EuroIntervention"},{"key":"5299_CR44","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMRA2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"Hahn\u00a0RT (2023) Tricuspid regurgitation. N\u00a0Engl J Med 388:1876\u20131891. https:\/\/doi.org\/10.1056\/NEJMRA2216709","journal-title":"N Engl J Med"},{"key":"5299_CR45","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.jacc.2017.10.039","volume":"70","author":"CJ Zack","year":"2017","unstructured":"Zack\u00a0CJ, Fender\u00a0EA, Chandrashekar\u00a0P et\u00a0al (2017) National trends and outcomes in isolated tricuspid valve surgery. J\u00a0Am Coll Cardiol 70:2953\u20132960","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR46","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4244\/EIJ-D-21-00695","volume":"17","author":"F Praz","year":"2021","unstructured":"Praz\u00a0F, Muraru\u00a0D, Kreidel\u00a0F et\u00a0al (2021) Transcatheter treatment for tricuspid valve disease. EuroIntervention 17:791\u2013808. https:\/\/doi.org\/10.4244\/EIJ-D-21-00695","journal-title":"EuroIntervention"},{"key":"5299_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2024.10.086","author":"HL Gilbert","year":"2024","unstructured":"Gilbert\u00a0HL, Tang\u00a0M, Rebecca\u00a0T, Hahn\u00a0M, Brian\u00a0K, Whisenant\u00a0M et\u00a0al (2024) Tricuspid transcatheter edge-to-edge repair for severe tricuspid regurgitation: 1\u2011year outcomes from the TRILUMINATE randomized cohort. J\u00a0Am Coll Cardiol. https:\/\/doi.org\/10.1016\/J.JACC.2024.10.086","journal-title":"J Am Coll Cardiol"},{"key":"5299_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2024.21189","author":"E Donal","year":"2024","unstructured":"Donal\u00a0E, Dreyfus\u00a0J, Leurent\u00a0G et\u00a0al (2024) Transcatheter edge-to-edge repair for severe isolated tricuspid regurgitation: the Tri.Fr randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/JAMA.2024.21189","journal-title":"JAMA"},{"key":"5299_CR49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2401918\/SUPPL_FILE\/NEJMOA2401918_DATA-SHARING.PDF","author":"RT Hahn","year":"2024","unstructured":"Hahn\u00a0RT, Makkar\u00a0R, Thourani\u00a0VH et\u00a0al (2024) Transcatheter valve replacement in severe tricuspid regurgitation. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2401918\/SUPPL_FILE\/NEJMOA2401918_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"5299_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2024.09.009","author":"JL Cavalcante","year":"2024","unstructured":"Cavalcante\u00a0JL, Scherer\u00a0M, Fukui\u00a0M et\u00a0al (2024) Advanced imaging assessment of the impact of tricuspid regurgitation on cardiac remodeling: the TRILUMINATE pivotal imaging substudy. J\u00a0Am Coll Cardiol. https:\/\/doi.org\/10.1016\/J.JACC.2024.09.009","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05299-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05299-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05299-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:46:46Z","timestamp":1748965606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05299-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5299"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05299-w","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"3 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.S.\u00a0Nettersheim declares that he has no competing interests. S.\u00a0Baldus received research funding and speaker honoraria from Abbott, Edwards Lifesciences, and Bayer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}